NYSE · SIC 6324
End-of-day closes; the latest point is the live 15-min-delayed price · split & dividend adjusted · chart by TradingView
UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals. The OptumRx segment provides pharmacy care services and programs, including retail network contracting, home delivery, specialty and compounding pharmacy, and purchasing and clinical capabilities.
Roles derived from SEC Form 4 filings.
Actuals from SEC filings; YoY vs the year-ago quarter. Analyst estimates & surprise require a data feed (coming soon).
| Line item | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $257.1B | $287.6B | $324.2B | $371.6B | $400.3B | $447.6B |
| Gross profit | — | — | — | — | — | — |
| Operating income | $22.4B | $24.0B | $28.4B | $32.4B | $32.3B | $19.0B |
| Net income | $15.4B | $17.3B | $20.1B | $22.4B | $14.4B | $12.1B |
| Diluted EPS | $16.03 | $18.08 | $21.18 | $23.86 | $15.51 | $13.23 |
| Operating cash flow | $22.2B | $22.3B | $26.2B | $29.1B | $24.2B | $19.7B |
| Free cash flow | $20.1B | $19.9B | $23.4B | $25.7B | $20.7B | $16.1B |
| Gross margin | — | — | — | — | — | — |
| Operating margin | 8.7% | 8.3% | 8.8% | 8.7% | 8.1% | 4.2% |
| Net margin | 6.0% | 6.0% | 6.2% | 6.0% | 3.6% | 2.7% |
| Line item | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $98.9B | $100.8B | $100.8B | $109.6B | $111.6B | $113.2B | $113.2B | $111.7B |
| Gross profit | — | — | — | — | — | — | — | — |
| Operating income | $7.9B | $8.7B | $7.8B | $9.1B | $5.2B | $4.3B | $380.0M | $9.0B |
| Net income | $4.2B | $6.1B | $5.5B | $6.3B | $3.4B | $2.3B | $10.0M | $6.3B |
| Diluted EPS | $4.54 | $6.51 | $5.99 | $6.85 | $3.74 | $2.59 | $0.05 | $6.90 |
| Operating cash flow | $6.7B | $13.9B | $2.4B | $5.5B | $7.2B | $5.9B | $1.1B | $8.9B |
| Free cash flow | $5.9B | $13.0B | $1.5B | $4.6B | $6.3B | $5.1B | $160.0M | $8.1B |
| Gross margin | — | — | — | — | — | — | — | — |
| Operating margin | 8.0% | 8.6% | 7.7% | 8.3% | 4.6% | 3.8% | 0.3% | 8.0% |
| Net margin | 4.3% | 6.0% | 5.5% | 5.7% | 3.1% | 2.1% | 0.0% | 5.6% |
Consensus revenue & EPS estimates and price targets will appear here once a forward-estimates data feed is connected.
| Date | Insider | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| 2026-07-01 | Noseworthy John H | Award | 206 | $0.00 | $0.00 | filing |
| 2026-07-01 | MONTGOMERY RICE VALERIE MD | Award | 220 | $0.00 | $0.00 | filing |
| 2026-07-01 | MCNABB FREDERICK WILLIAM III | Award | 250 | $0.00 | $0.00 | filing |
| 2026-07-01 | Gottlieb Scott | Award | 210 | $0.00 | $0.00 | filing |
| 2026-07-01 | Gil Kristen | Award | 206 | $0.00 | $0.00 | filing |
| 2026-07-01 | GARCIA PAUL R | Award | 132 | $0.00 | $0.00 | filing |
| 2026-07-01 | GARCIA PAUL R | Award | 88 | $0.00 | $0.00 | filing |
| 2026-07-01 | FLYNN TIMOTHY PATRICK | Award | 225 | $0.00 | $0.00 | filing |
| 2026-07-01 | Baker Charles D. | Award | 220 | $0.00 | $0.00 | filing |
| 2026-06-23 | McSweeney Erin· EVP & Chief People Officer | Award | 48 | $0.00 | $0.00 | filing |
| 2026-06-23 | Noseworthy John H | Award | 41 | $0.00 | $0.00 | filing |
| 2026-06-23 | GARCIA PAUL R | Award | 13 | $0.00 | $0.00 | filing |
| 2026-06-23 | MONTGOMERY RICE VALERIE MD | Award | 41 | $0.00 | $0.00 | filing |
| 2026-06-23 | Gil Kristen | Award | 8 | $0.00 | $0.00 | filing |
| 2026-06-23 | Gottlieb Scott | Award | 3 | $0.00 | $0.00 | filing |
| 2026-06-23 | Conway Patrick Hugh· Chief Executive Officer, Optum | Award | 82 | $0.00 | $0.00 | filing |
| 2026-06-23 | Noel Timothy John· Chief Executive Officer, UHC | Award | 76 | $0.00 | $0.00 | filing |
| 2026-06-23 | Zaetta Christopher R· EVP & Chief Legal Officer | Award | 61 | $0.00 | $0.00 | filing |
| 2026-06-23 | DeVeydt Wayne S· Chief Financial Officer | Award | 112 | $0.00 | $0.00 | filing |
| 2026-06-23 | HEMSLEY STEPHEN J· CEO, UHG | Award | 46 | $0.00 | $0.00 | filing |
| 2026-06-23 | Stankiewicz Dennis Andrew· Chief Accounting Officer | Award | 51 | $0.00 | $0.00 | filing |
| 2026-06-23 | Baker Charles D. | Award | 13 | $0.00 | $0.00 | filing |
| 2026-06-23 | MCNABB FREDERICK WILLIAM III | Award | 50 | $0.00 | $0.00 | filing |
| 2026-06-23 | FLYNN TIMOTHY PATRICK | Award | 61 | $0.00 | $0.00 | filing |
| 2026-06-05 | Conway Patrick Hugh· Chief Executive Officer, Optum | Tax withholding | 687 | $399.47 | $274,380.36 | filing |
Showing the latest 25 transactions — full history in the linked SEC filings.
Fundamentals & filings from SEC EDGAR. Prices adjusted for splits & dividends. Not investment advice.